MedTrace Logo

Significance of Circulating Tumor Cells in the Treatment of Gastric and Rectal Cancer

NCT02955173 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 467

Last updated 2021-10-05

No results posted yet for this study

Summary

The primary purpose of this study is to compare both short-term and long-term treatment effect of laparoscopic vs. open approach on progressive gastric and rectal cancer, based on circulating tumor cell (CTC) test results as well as disease-free survivals, and figure out principles of laparoscopic approach for progressive gastric and rectal cancer. Secondary purpose is to establish an evaluation system for laparoscopic surgery for progressive gastric and rectal cancer treatment using CTC as a biomarker.

Conditions

Interventions

PROCEDURE

Surgery

Laparoscopic or open surgery for resection of gastric or rectal cancer

Sponsors & Collaborators

  • Peking University People's Hospital

    collaborator OTHER

  • Qilu Hospital of Shandong University

    lead OTHER

Principal Investigators

  • Sanyuan Hu, M.D. Ph.D. · Qilu Hospital of Shandong University

Study Design

Allocation
NON_RANDOMIZED
Purpose
SCREENING
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-12-31
Primary Completion
2020-12-14
Completion
2021-08-03

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02955173 on ClinicalTrials.gov